-
Mashup Score: 0Overview ⋮ Herpes Zoster Prevention in the Immunocompromised — Featuring Curbside Consults ⋮ Blackthorn ⋮ Events - 7 month(s) ago
Beautiful and powerful native Salesforce events platform.
Source: events.vindicocme.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Healio Rheumatology | Current Issue - Healio - 10 month(s) ago
Read articles that appeared in the print edition of Healio Rheumatology. Healio is your trusted source for rheumatology news.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
May 11 marked the “official end” of the #COVID19 emergency, but @LCalabreseDO cautions that it still isn’t over. There are 2 #pandemics: One for the healthy and #vaccinated and one for the #immunocompromised 😷 https://t.co/RkIQx7BtiC #RheumTwitter #MedTwitter https://t.co/YG3ntDJsh8
-
-
Mashup Score: 2Healio Rheumatology | Current Issue - Healio - 10 month(s) ago
Read articles that appeared in the print edition of Healio Rheumatology. Healio is your trusted source for rheumatology news.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
⏱️Got #60Seconds ? @LCalabreseDO is “very worried” about #PrivateEquity in the business of #rheumatology and notes that the #COVID19 emergency is still not over for #immunocompromised patients 😷 Find out more here: https://t.co/RkIQx7BtiC #RheumTwitter #MedTwitter https://t.co/Qtzrw7Qs9p
-
-
Mashup Score: 0Data Show Changes in Vaccine Trials During COVID-19 Pandemic - 1 year(s) ago
Study results indicate a decrease in the exclusion of older adults but no significant change for individuals who are immunocompromised.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
During the COVID-19 pandemic, there was a decrease in the exclusion of older adults in vaccine trials, but there was no significant change in the inclusion of individuals who are #immunocompromised. #covid19 Read More: https://t.co/bYflIZMb5x
-
-
Mashup Score: 9Coronavirus (COVID-19) Update: FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines - 1 year(s) ago
The FDA amended the EUAs of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
Categories: Latest Headlines, Oncologists1Tweet-
People <65 who are not #immunocompromised are not yet elig for a 2nd bivalent #boostershot. Needed updates to the #COVID19 bivalent #booster shots (based on dominant/emerging #COVIDvariants) will be discussed at a 06/2023 advisory comm mtg. https://t.co/uFQVxQNKjd #MedTwitter
-
-
Mashup Score: 1COVID-19 Guideline, Part 1: Treatment and Management - 1 year(s) ago
IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments related to the clinical practice guideline for the treatment and management of COVID-19.
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet-
ICYMI, #IDSAGuidelines now recommend AGAINST routine use of #convalescentplasma among immunocompetent patients & suggests against use among #immunocompromised patients hospitalized with COVID-19. https://t.co/XdWcNHa1m7 https://t.co/TAqM8KQoKa
-
-
Mashup Score: 1Opinion | Do We Need a Spring COVID-19 Booster? - 1 year(s) ago
A look at the data, particularly for high-risk groups
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Is a #COVID19booster necessary for the spring season? 🌷 In this #OpEd, @jeremyfaust & @dr_kkjetelina share that if you're #immunocompromised and/or an older adult with a #comorbidity, a spring booster may be a good idea to stay ahead of the #virus. https://t.co/hE0DUTX759
-
-
Mashup Score: 1
Losing focus on monoclonals means neglecting those who need them most: the immunocompromised
Source: www.medpagetoday.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
What Happened to the #MonoclonalAntibodies for #COVID19? — Losing focus on monoclonals means neglecting those who need them most: the #Immunocompromised @jeremyfaust MD https://t.co/USSISJyrJA @MedpageToday #FaustFiles
-
-
Mashup Score: 2Updated COVID-19 Guidance for People Who Are Immunocompromised - 1 year(s) ago
In late January, the US Food and Drug Administration announced that Evusheld (the combined monoclonal antibodies tixagevimab and cilgavimab) is not currently authorized for emergency use because it’s likely ineffective against more than 90% of SARS-CoV-2 variants now circulating in the US. Evusheld…
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Updated #COVID-19 Guidance for People Who Are #Immunocompromised https://t.co/5ZL345rqNr
-
-
Mashup Score: 2Information for Persons Who Are Immunocompromised ... - 1 year(s) ago
This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.
Categories: Hem/Oncs, Latest HeadlinesTweet-
⚠️ IMPORTANT #OncTwitter, people w/ #cancer, #transplant, or #immunocompromised: FDA has halted use of Evusheld because it does not work against ~95% of current #CovidVariants circulating in 🇺🇸. 😷 up. #leusm #lymsm #mmsm #bmt #Oncoalert @HemOncWomenDocs https://t.co/bsy2fjkB7O
-
*SPONSORED POST* #CME #CPE Lunch Sympo "Herpes Zoster Prevention in the Immunocompromised" Wed, Oct 11, 10:30am – 1:00pm ET The Westin Boston Seaport Districtor virtually! Register: https://t.co/WYiHIaOoeW #HerpesZoster #Immunocompromised #MedicalEducation #IDWeek2023 https://t.co/Cr26VbtZrN